Interestingly, the use of inhibitors targeting the ileal bile acid transporter (IBAT), which regulates bile acid absorption in the small intestine, has been shown to delay liver remodeling in BA patients (18, 19). This evidence concerns the gene SLC10A2 and breast angiosarcoma.